ArticleClinical and translational medicine2022

APE1 shRNA-loaded cancer stem cell-derived extracellular vesicles reverse Erlotinib resistance in non-small cell lung cancer via the IL-6/STAT3 signalling.

Chun-Han Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.